Karen M. Davis-Fleischer, PhD and Gail E. Besner

Department of Surgery, Children’s Hospital and The Ohio State University, 700 Children’s Drive, Columbus, Ohio, 43205

Received 2/20/98 Accepted 2/25/98

6. REFERENCES

1. Besner, G., S. Higashiyama & M. Klagsbrun: Isolation and characterization of a macrophage-derived heparin binding growth factor. Cell Regulation 1, 811-819, (1990)
2. Higashiyama, S., J.A. Abraham, J. Miller, J.C. Fiddes & M. Klagsbrun: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 936-939, (1991)
3. Shoyab, M., V.L. McDonald, J.G. Bradley & G.J. Todaro: Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. Natl. Acad. Sci., U.S.A. 85, 6528-6532, (1988)
4. Shoyab, M., G.D. Plowman, V.L. McDonald, J.G. Bradley & G.J. Todaro: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243, 1074-1076, (1989)
5. Brigstock, D.R., C.L. Steffen, G.Y. Kim, R.K. Vegunta, J.R. Diehl & P.A. Harding: Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. J. Biol. Chem. 272, 20275-20282, (1997)
6. Yayon, A., M. Klagsbrun, J.D. Esko, P. Leder & D.M. Ornitz: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848, (1991)
7. Klagsbrun, M. & A. Baird: A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231, (1991)
8. Rapraeger, A.C., A. Krufka & B.B. Olwin: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708, (1991)
9. Besner, G.E., D. Whelton, M.A. Crissman-Combs, C.L. Steffen, G.Y. Kim & D.R. Brigstock: Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments. Growth Factors 7, 289-296, (1992)
10. Higashiyama, S., J.A. Abraham & M.J. Klagsbrun: Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122, 933-940, (1993)
11. Marikovsky, M., K. Breuing, P.Y. Liu, E. Eriksson, S. Higashiyama, P. Farber, J. Abraham & M. Klagsbrun: Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci., U.S.A. 90, 3889-3893, (1993)
12. Aviezer, D. & A. Yayon: Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci., U.S.A. 91, 12173-12177, (1994)
13. Cook, P.W., N.M. Ashton, C.E. Karkaria, D.C. Siess & G.D Shipley: Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J. Cell. Phys. 163, 418-429, (1995)
14. Cook, P.W., D. Damm, B.L. Garrick, K.M. Wood, C.E. Karkaria, S. Higashiyama, M. Klagsbrun & J.A. Abraham: Carboxy-terminal truncation of leucine₇₆ converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor. J. Cell. Phys. 163, 407-417, (1995)
15. Thompson, S.A., S. Higashiyama, K. Wood, N.S. Pollitt, D. Damm, G. McEnroe, B. Garrick, N. Ashton, K. Lau, N. Hancock, M. Klagsbrun & J.A. Abraham: Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J. Biol. Chem. 269, 2541-2549, (1994)
16. Naglich, J.G., J.E. Metherall, D.W. Russell & L. Eidels: Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69, 1051-1061, (1992)
17. Iwamoto, R., S. Higashiyama, T. Mitamura, N. Taniguchi, M. Klagsbrun & E. Mekada: Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13, 2322-2330, (1994)
18. Hooper, K.P. & L. Eidels: Localization of a critical diphtheria toxin-binding domain to the C-terminus of the mature heparin-binding EGF-like growth factor region of the diphtheria toxin receptor. Biochem. Biophys. Res. Commun. 206, 710-717, (1995)
19. Mitamura, T., S. Higashiyama, N. Taniguchi, M. Klagsbrun & E. Mekada: Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270, 1015-1019, (1995)
20. Higashiyama, S., R. Iwamoto, K. Goishi, G. Raab, N. Taniguchi, M. Klagsbrun & E. Mekada: The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Biol. Chem. 128, 929-938, (1995)
21. Sakuma, T., S. Higashiyama, S. Hosoe, S. Hayashi & N. Taniguchi: CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain. J. Biochem. 122, 474-480, (1997)
22. Fen, Z., M.S. Dhadley, M. Yoshizumi, R.J. Hilkert, T. Quertermous, R.L. Eddy, T.B. Shows & M-E. Lee: Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor- like growth factor/diphtheria toxin receptor. Biochem. 32, 7932-7938, (1993)
23. Pathak, B.G., D.J. Gilbert, C.A. Harrison, N.C. Luetteke, X. Chen, M. Klagsbrun, G.D. Plowman, N.G. Copeland, N.A. Jenkins & D.C. Lee: Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (Btc), and heparin-binding EGF (Hegfl). Genomics 28, 116-118, (1995)
24. Harding, P.A., D.R. Brigstock, L. Shen, M.A. Crissman-Combs & G. Besner: Characterization of the gene encoding murine heparin-binding epidermal growth factor-like growth factor. Gene 169, 291-292, (1996)
25. Abraham, J.A., D. Damm, A. Bajardi, J. Miller, M. Klagsbrun & A.B. Ezekowitz: Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 190, 125-133, (1993)
26. Kim, G.Y., G.E. Besner, C.L. Steffen, D.W. McCarthy, M.T. Downing, M.H. Luquette, M.S. Abad & D.R. Brigstock: Purification of heparin-binding epidermal growth factor-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues. Biol. of Reprod. 52, 561-571, (1995)
27. Higashiyama, S., K. Lau, G.E. Besner, J.A. Abraham & M. Klagsbrun: Structure of heparin-binding EGF-like growth factor. J. Biol. Chem. 267, 6205-6212, (1992)
28. McCarthy, D.W., M.T. Downing, D.R. Brigstock, M.H. Luquette, K.D. Brown, M.S. Abad & G.E. Besner: Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J. Invest. Derm. 106, 49-56, (1996)
29. Davis, K.M., D.R. Brigstock, P.R. Johnson, M.A. Crissman-Combs, D.W. McCarthy, M.T. Downing & G.E. Besner: Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Protein Expression and Purification 8, 57-67, (1996)
30. Ono, M.: Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim). Eur. J. Cancer 30A, Suppl. 3, S7-S11, (1994)
31. Hosaka, M., M. Nagahama, W.S. Kim, T. Watanabe, K. Hatsuzawa, J. Ikemizu, K. Murakami & K.J. Nakayama: Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J. Biol. Chem. 266, 12127-12130, (1991)
32. Crissman-Combs, M.A., D.R. Brigstock & G.E. Besner: Production and characterization of recombinant human HB-EGF in Escherichia coli. Mol. Biol. Cell 4 Suppl., 20a, (1993)
33. Raab, G., S. Higashiyama, S. Hetelekidis, J.A. Abraham, D. Damm, M. Ono & M. Klagsbrun: Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem Biophys. Res. Commun. 204, 592-597, (1994)
34. Goishi, K., S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa, E. Mekada & N. Taniguchi: Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967-980, (1995)
35. Pandiella, A. & J. Massague: Multiple signals activate the cleavage of the membrane transforming growth factor-alpha precursor. J. Biol. Chem. 266, 5769-5773, (1991)
36. Lanzrein, M., O. Garred, S. Olsnes & K. Sandvig: Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells. Biochem. J. 310, 285-289, (1995)
37. Suzuki, M., G. Raab, M.A. Moses, C.A. Fernandez & M. Klagsbrun: Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272, 31730-31737, (1997)
38. Loukianov, E., T. Loukianova, A. Wiedlocha & S. Olsnes: Expression of mRNA for a short form of heparin-binding EGF-like growth factor. Gene 195, 81-86, (1997)
39. Massague, J. & A. Pandiella: Membrane-anchored growth factors. Annu. Rev. Biochem. 62, 515-541, (1993)
40. Vaughan, T.J., J.C. Pascall & K.D. Brown: Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem. J. 287, 681-684, (1992)
41. Chen, X., G. Raab, U. Deutsch, J. Zhang, R.M. Ezzell & M. Klagsbrun: Induction of heparin-binding EGF-like growth factor expression during myogenesis. J. Biol. Chem 270, 18285-18294, (1995)
42. Zhang, Z., C. Funk, D. Roy, S. Glasser & J. Mullholland: Heparin-binding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology 134, 1089-1094, (1994)
43. Das, S.K., X-N. Wang, B.C. Paria, D. Damm, J.A. Abraham, M. Klagsbrun, G.K. Andrews & S.K. Dey: Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 120, 1071-1083, (1994)
44. Raab, G., K. Kover, B.C. Paria, S.K. Dey, R.M. Ezzell & M. Klagsbrun: Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor. Development 122, 637-645, (1996)
45. Yoo, H-J., D.H. Barlow & H.J. Mardon: Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev. Genet. 21, 102-108, (1997)
46. Eastwood, G.L.: Gastrointestinal epithelial renewal. Gastroenterology 72, 962-975, (1977)
47. Lipkin, M.: Growth and development of gastrointestinal cells. Annu. Rev. Physiol. 47, 175-197, (1985)
48. Murayama, Y., J-I. Miyagawa, S. Higashiyama, S. Kondo, M. Yabu, K. Isozaki, Y. Kayanoki, S. Kanayama, Y. Shinomura, N. Taniguchi & Y. Matsuzawa: Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 109, 1051-1059, (1995)
49. Miyazaki, Y., Y. Shinomura, S. Higashiyama, S. Kanayama, Y. Higashimoto, S. Tsutsui, S. Zushi, N. Taniguchi & Y. Matsuzawa: Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells. Biochem. Biophys. Res. Commun. 223, 36-41, (1996)
50. Pillai, S.B., M.A. Turman & G.E. Besner: Heparin-binding EGF-like growth factor (HB-EGF) is cytoprotective for intestinal epithelial cells exposed to hypoxia. J. Pediatr. Surg. (in press)
51. Pillai, S.B., M.H. Luquette, P.T. Nowicki & G.E. Besner: Heparin-binding EGF-like growth factor reduces intestinal injury after ischemia. Mol. Biol. Cell 8 Suppl., 8a, (1997)
52. Miyazaki, Y., Y. Shinomura, S. Tsutsui, Y. Yasunaga, S. Zushi, S. Higashiyama, N. Taniguchi & Y. Matsuzawa: Oxidative stress increases gene expression of heparin-binding EGF-like growth factor and amphiregulin in cultured rat gastric epithelial cells. Biochem. Biophys. Res. Commun. 226, 542-546, (1996)
53. Kaneto, H., J-I. Miyagawa, Y. Kajimoto, K. Yamamoto, H. Watada, Y. Umayahara, T. Hanafusa, Y. Matsuzawa, Y. Yamasaki, S. Higashiyama & N. Taniguchi: Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. J. Biol. Chem. 272, 29137-29143, (1997)
54. Ross, R.: The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314, 488-500, (1986)
55. Klagsbrun, M. & E.R. Edelman: Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Atherosclerosis 9, 269-278, (1989)
56. Yoshizumi, M., S. Kourembanas, D.H. Temizer, R.P. Cambria, T. Quertermous & M.E. Lee: Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 267, 9467-9469, (1992)
57. Dluz, S.M., S. Higashiyama, D. Damm, J.A. Abraham & M. Klagsbrun: Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. J. Biol. Chem. 268, 18330-18334, (1993)
58. Majesky, M.W., M.A. Reidy, P.D. Bowen, C.E. Hart, J.N. Wilcox & S.M. Schwartz: PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 11, 2149-2158, (1990)
59. Igura, T., S. Kawata, J-I. Miyagawa, Y. Inui, S. Tamura, K. Fukuda, K. Isozaki, K. Yamamori, N. Taniguchi, S. Higashiyama & Y. Matsuzawa: Expression of heparin-binding epidermal growth factor-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries. Arterioscler. Thromb. Vasc. Biol. 16, 1524-1531, (1996)
60. Miyagawa, J-I., S. Higashiyama, S. Kawata, Y. Inui, S. Tamura, K. Yamamoto, M. Nishida, T. Nakamura, S. Yamashita, Y. Matsuzawa & N. Taniguchi: Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95, 404-411, (1995)
61. Nakata, A., J-I. Miyagawa, S. Yamashita, M. Nishida, R. Tamura, K. Yamamori, T. Nakamura, S. Nozaki, K. Kameda-Takemura, S. Kawata, N. Taniguchi, S. Higashiyama & Y. Matsuzawa: Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Circulation 94, 2778-2786, (1996)
62. Reape, T.J., V.J. Wilson, J.M. Kanczler, J.P.T. Ward, K.G. Burnand & C.R. Thomas: Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue. J. Mol. Cell. Cardiol. 29, 1639-1648, (1997)
63. Kume, N. & M.A. Gimbrone, Jr.: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93, 907-911, (1994)
64. Nakano, T., E.W. Raines, J.A. Abraham, M. Klagsbrun & R. Ross: Lysophosphatidylcholine up-regulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci., U.S.A. 91, 1069-1073, (1994)
65. Nishi, E., N. Kume, H. Ochi, H. Moriwaki, Y. Wakatsuki, S. Higashiyama, N. Taniguchi & T. Kita: Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes. Circ. Res. 80, 638-644, (1997)
66. Powell, P.P., M. Klagsbrun, J.A. Abraham & R.C. Jones: Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143, 784-793, (1993)
67. Ohashi, Y., S. Motojima, T. Fukuda & S. Makino: Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am. Rev. Respir. Dis. 145, 1469-1476, (1992)
68. Azzawi, M., P.W. Johnson, S. Majumdar, A.B. Kay & P.K. Jeffery: T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145, 1477-1482, (1992)
69. Berman, J.S. & P. Weller: Airway eosinophils and lymphocytes in asthma: birds of a feather? Am. Rev. Respir. Dis. 145, 1246-1248, (1992)
70. Nakagawa, T., Y. Hayase, M. Sasahara, M. Haneda, R. Kikkawa, S. Higashiyama, N. Taniguchi & F. Hazama: Distribution of heparin-binding EGF-like growth factor protein and mRNA in the normal rat kidneys. Kidney Int. 51, 1774-1779, (1997)
71. Lee, Y-J., S-J. Shin, S-R. Lin, M-S. Tan & J-H. Tsai: Increased expression of heparin-binding epidermal growth factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats. Biochem. Biophys. Res. Commun. 207, 216-222, (1995)
72. Toback, F.G.: Regeneration after acute tubular necrosis. Kidney Int. 41, 226-246, (1992)
73. Homma, T., M. Sakai, H.F. Cheng, T. Yasuda, R.J. Coffey & R.C. Harris: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J. Clin. Invest. 96, 1018-1025 (1995)
74. Sakai, M., M-Z. Zhang, T. Homma, B. Garrick, J.A. Abraham, J.A. McKanna & R.C. Harris: Production of heparin-binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. J. Clin. Invest. 99, 2128-2138, (1997)
75. Takemura, T., S. Kondo, T. Homma, M. Sakai & R.C. Harris: The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J. Biol. Chem. 272, 31036-31042, (1997)
76. Freeman, M.R., J.J. Yoo, G. Raab, S. Soker, R.M. Adam, F.X. Schneck, A.A. Renshaw, M. Klagsbrun & A. Atala: Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the bladder. J. Clin. Invest. 99, 1028-1036, (1997)
77. Ito, N., S. Kawata, S. Tamura, S. Kiso, H. Tsushima, D. Damm, J.A. Abraham, S. Higashiyama, N. Taniguchi & Y. Matsuzawa: Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Biochem. Biophys. Res. Commun. 198, 25-31, (1994)
78. K78. iso, S., S. Kawata, S. Tamura, N. Ito, H. Tsushima, A. Yamada, S. Higashiyama, N. Taniguchi & Y. Matsuzawa: Expression of heparin-binding EGF-like growth factor in rat liver injured by carbon tetrachloride or D-galactosamine. Biochem. Biophys. Res. Commun. 220, 285-288, (1996)
79. Mograbi, B., N. Rochet, V. Imbert, I. Bourget, R. Bocciardi, C. Emiliozzi & B. Rossi: Human monocytes express amphiregulin and heregulin growth factors upon activation. Eur. Cytokine Netw. 8, 73-81, (1997)
80. Cribbs, R., M. Luquette & G. Besner: Acceleration of partial-thickness burn wound healing with topical application of heparin-binding EGF-like growth factor (HB-EGF). J. Burn Care and Rehab. (in press)
81. Kobrin, M.S., H. Funatomi, H. Friess, M.W. Buchler, P. Stathis & M. Korc: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 202, 1705-1709, (1994)
82. Miyoshi, E., S. Higashiyama, T. Nakagawa, K. Suzuki, M. Horimoto, N. Hayashi, H. Fusamoto, T. Kamada & N. Taniguchi: High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis. Int. J. Cancer 68, 215-218, (1996)
83. Naef, M., M. Yokoyama, H. Friess, M.W. Buchler & M. Korc: Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int. J. Cancer 66, 315-321, (1996)
84. Downing, M.T., D.R. Brigstock, M.H. Luquette, M.A. Crissman-Combs & G.E. Besner: Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers. Histochem. J. 29, 735-744, (1997)
85. Rundhaug, J.E., I. Gimenez-Conti, M.C. Stern, I.V. Budunova, K. Kiguchi, D.K. Bol, L.G. Coghlan, C.J. Conti, J. DiGiovanni, S.M. Fischer, L.D. Winberg & T.J. Slaga: Changes in protein expression during multistage mouse skin carcinogenesis. Mol. Carcinog. 20, 125-136, (1997)
86. Chong, I-W., S-R. Lin, M-S. Lin, M-S. Huang, M-S. Tsai & J-J. Hwang: Heparin-binding epidermal growth factor-like growth factor and transforming growth factor-alpha in human non-small cell lung cancers. J. Formos Med. Assoc. 96, 579-585, (1997)
87. Takada, A., K. Ohmori, N. Takahashi, K. Tsuyuoka, K. Yago, K. Zenita, A. Hasegawa & R. Kannagi: Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem. Biophys. Res. Commun. 179, 713-719, (1991)
88. Hakomori, S-I.: Le^x and related structures as adhesion molecules. Histochem. J. 24, 771-776, (1992)
89. Majuri, M-L., P. Mattila & R. Renkonen: Recombinant E-selectin-protein mediates tumor cell adhesion via sialyl-Le(a) and sialyl-Le(x). Biochem. Biophys. Res. Commun. 182, 1376-1382, (1992)
90. Narita, T., N. Kawakami-Kimura, M. Sato, N. Matsuura, S. Higashiyama, N. Taniguchi & R. Kannagi: Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 53, 374-381, (1996)
91. Sato, M., T. Narita, N. Kawakami-Kimura, S. Higashiyama, N. Taniguchi, S. Akiyama, T. Hashimoto, T. Manabe & R. Kannagi: Increased expression of integrins by heparin-binding EGF-like growth factor in human esophageal cancer cells. Cancer Letters 102, 183-191, (1996)
92. Schlessinger, J. & A. Ullrich: Growth factor signaling by receptor tyrosine kinases. Neuron 9, 383-391, (1992)
93. Beerli, R.R. & N.E. Hynes: Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271, 6071-6076, (1996)
94. Blotnick, S., G.E. Peoples, M.R. Freeman, T.J. Eberlein & M. Klagsbrun: T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci., U.S.A. 91, 2890-2894, (1994)
95. Zhang, K., J. Sun, D. Wen, D. Chang, A. Thomason & S.K. Yoshinaga: Transformation of NIH 3T3 cells by HER3 and HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem. 271, 3884-3890, (1996)
96. Elenius, K., S. Paul, G. Allison, J. Sun & M. Klagsbrun: Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16, 1268-1278, (1997)
97. Davis-Fleischer, K.: An analysis of heparin-binding EGF-like growth factor (HB-EGF) O-glycosylation. Doctoral Dissertation, The Ohio State University, (1997)
98. Lipkin, M.: Proliferation and differentiation of normal and diseased gastrointestinal cells. In: Physiology of the gastrointestinal tract. Eds: L.R. Johnson, J. Christensen, M.J. Jackson, E.D. Jacobson, J.H. Walsh, Raven Press, N.Y. 1, 255-284, (1987)